Hulya Sahin Ozkan
4PUBLICATIONS
49CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.Wungki Park, Catherine A O'Connor, Joanne F Chou
|Sep 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.Wungki Park, Catherine O'Connor, Joanne Chou
|Jul 08, 2024
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer.Anupriya Singhal, Hannah C Styers, Jonathan Rub
|Jul 19, 2020
Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma.Hulya Sahin Ozkan, Mustafa Umit Ugurlu, Perran Fulden Yumuk
Pageof 1
Frequent Collaborators
3 joint publications
Olca Basturk
2 joint publications
Walid Chatila
2 joint publications
Elias Karnoub
2 joint publications
Anna Varghese
2 joint publications
Shigeaki Umeda
2 joint publications
Daniel Muldoon
2 joint publications
Marc Hilmi
2 joint publications
Fiyinfolu Balogun
2 joint publications
Maria Perry
2 joint publications
Wungki Park
